PlasmidFactory GmbH and the Fraunhofer Institute for Cell Therapy and Immunology IZI have signed a Memorandum of Understanding to combine expertise in cell therapy process development and GMP ...

For each of its vector programs, the goal is to reduce the quantity of the vector needed to deliver an effective dose. “That’s a safety issue, and also a cost of goods issue,” Revah says. Therefore, ...